statistiche ricercatore

Continente	#
NA - Nord America	850
EU - Europa	698
AS - Asia	304
SA - Sud America	57
AF - Africa	19
Continente sconosciuto - Info sul continente non disponibili	18
OC - Oceania	1
Totale	1.947

Nazione	#
US - Stati Uniti d'America	825
RU - Federazione Russa	193
IT - Italia	119
GB - Regno Unito	113
SG - Singapore	107
IE - Irlanda	86
CN - Cina	84
BR - Brasile	48
VN - Vietnam	48
SE - Svezia	40
UA - Ucraina	34
DE - Germania	32
FR - Francia	31
HK - Hong Kong	22
FI - Finlandia	15
CA - Canada	14
KR - Corea	13
ZA - Sudafrica	11
IN - India	9
CZ - Repubblica Ceca	8
ES - Italia	7
MX - Messico	7
TR - Turchia	5
BE - Belgio	4
AR - Argentina	3
LT - Lituania	3
PL - Polonia	3
TN - Tunisia	3
VE - Venezuela	3
BD - Bangladesh	2
GR - Grecia	2
ID - Indonesia	2
IQ - Iraq	2
IR - Iran	2
MA - Marocco	2
NG - Nigeria	2
PA - Panama	2
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BG - Bulgaria	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CL - Cile	1
CO - Colombia	1
CY - Cipro	1
DK - Danimarca	1
EC - Ecuador	1
EE - Estonia	1
GT - Guatemala	1
IL - Israele	1
JM - Giamaica	1
KW - Kuwait	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LI - Liechtenstein	1
LV - Lettonia	1
NL - Olanda	1
PH - Filippine	1
YE - Yemen	1
Totale	1.929

Nome	#
2-Aminothiazolones as anti-hiv agents that act as gp120-cd4 inhibitors	341
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X	267
One-pot multicomponent synthesis of 2,3-dihydropyrans: new access to furanose-pyranose 1,3-C-C-linked-disaccharides	229
A Practical One-Pot Two-Step Protocol for the Microwave-Assisted Synthesis of Highly Functionalized Rhodanine Derivatives	228
Alkyne-enol ether cross-metathesis in the presence of CuSO. Direct formation of 3-substituted crotonaldehydes in aqueous medium	221
Novel broad spectrum virucidal molecules against enveloped viruses	181
Stereoselective protecting group free synthesis of D,L-gulose ethyl glycoside via multicomponent enyne cross methatesis-hetero Diels-Alder reaction	167
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme	158
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinoma	155
Totale	1.947

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	98	0	15	3	3	9	2	7	3	7	12	15	22
2022/2023	162	9	16	19	21	27	26	4	15	15	6	4	0
2023/2024	136	4	1	6	8	4	34	48	1	0	8	7	15
2024/2025	310	7	13	33	39	49	9	10	24	36	16	25	49
2025/2026	709	47	66	84	89	179	23	78	16	32	26	12	57
2026/2027	48	32	16	0	0	0	0	0	0	0	0	0	0
Totale													1.947